Metsera Issues Statement in Response to Litigation
PR Newswire —
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer: "Pfizer is trying to litigate its way to buying Metsera for a lower price than Novo Nordisk....